
Survival in patients with Acute Myelogenous Leukemia. The question at the time was whether the standard course of chemotherapy should be extended ('maintainance') for additional cycles.
aml
leukemia
data(cancer, package="survival")
time: | survival or censoring time |
status: | censoring status |
x: | maintenance chemotherapy given? (factor) |